Ionis Pharmaceuticals Inc. (IONS) stock forecast and price target
Price $29.06 · data as of November 13, 2026
12-month price target
Average target$68.48
Upside / downside+135.6%
Analysts23
ConsensusBuy
Low $41.00Average $68.48High $105.00
Gold marker: average target · white marker: today’s price ($29.06)
Analyst ratings
Strong buy 8Buy 13Hold 4Sell 0Strong sell 0
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $-2.42 | −56.9% | $920M |
| Next fiscal year ends December 31, 2027 | $-2.03 | +16.4% | $1.2B |
| Next quarter ends December 31, 2026 | $-0.93 | +18.6% | $182M |
| Quarter after ends December 31, 2026 | $-0.85 | +26.2% | $217M |
Consensus of the analysts covering Ionis Pharmaceuticals, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.
Frequently asked questions
What is the Ionis Pharmaceuticals stock price target?
The average 12-month target from 23 analysts is $68.48, 135.6% above the current price of $29.06 Targets range from $41.00 to $105.00.
Is Ionis Pharmaceuticals a buy according to analysts?
The consensus rating is “Buy” (8 strong buy, 13 buy, 4 hold). Ratings are opinions, not guarantees; this is not investment advice.
How much is Ionis Pharmaceuticals expected to earn?
Analysts expect EPS of $-2.42 for the fiscal year ending December 31, 2026 and $-2.03 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.